Geisinger Heart Institute, Wilkes-Barre, Pennsylvania.
Hôpital Cardiologique du Haut-Lêvêque CHU Bordeaux, Université Bordeaux, IHU LIRYC, Bordeaux, France.
J Am Coll Cardiol. 2017 Jun 27;69(25):3099-3114. doi: 10.1016/j.jacc.2017.05.005.
Cardiac pacing is an effective treatment for patients with bradycardia due to sinus node dysfunction or atrioventricular block. Despite decades of technological advances, the optimal ventricular pacing site to mimic normal human ventricular physiology and best hemodynamic response remains elusive. Beginning with atrial synchronous right ventricular (RV) apical pacing, the search has continued through alternate RV pacing sites, minimizing RV pacing, biventricular pacing, left ventricular (LV) pacing, and His-bundle pacing. Understanding the deleterious effects of long-term RV apical pacing in vulnerable populations has created tremendous interest in alternate pacing options. This paper reviews the current status of available pacing options, with particular focus on His-bundle pacing. Permanent His-bundle pacing has emerged as the leading candidate for physiological pacing because it provides nearly normal electrical activation of both ventricles and thereby avoids ventricular dyssynchrony. Synchronized LV pacing, multisite LV pacing, and LV endocardial pacing offer promise as novel pacing options in select patients.
心脏起搏是治疗窦房结功能障碍或房室传导阻滞引起的心动过缓患者的有效方法。尽管几十年来技术不断进步,但仍难以找到最佳的心室起搏部位来模拟正常人类心室生理和最佳血液动力学反应。从心房同步性右心室(RV)心尖起搏开始,人们一直在探索替代 RV 起搏部位,包括最小化 RV 起搏、双心室起搏、左心室(LV)起搏和希氏束起搏。了解长期 RV 心尖起搏对脆弱人群的有害影响,极大地激发了对替代起搏选择的兴趣。本文回顾了目前可用的起搏选择,特别关注希氏束起搏。永久性希氏束起搏已成为生理性起搏的首选,因为它几乎能正常地激活左右心室,从而避免心室不同步。同步性 LV 起搏、多部位 LV 起搏和 LV 心内膜起搏在某些特定患者中作为新型起搏选择具有广阔前景。